Nov-08(2)
December 21, 2015
No Comments
In this issue: Antitrust Damages Antonio Caruso, Ewoud Sakkers, Nov 30, 2008 Liability for Aiding and Abetting in EU
CPI
Nov-08(1)
December 21, 2015
No Comments
The EC Pharmaceutical Report Kent Bernard, Nov 12, 2008 The 2008 EC Sector Inquiry Regarding Pharmaceuticals: What Does It Mean
Oct-08(2)
December 21, 2015
No Comments
In this issue: Ex Post Assessment of Regulation 1/2003 Stephen Kinsella, Anouck Meier, Oct 29, 2008 Decentralization or the Law
FEB-10(1)
December 21, 2015
No Comments
In this issue: Welcome to the home page of The CPI Antitrust Chronicle (formerly GCP Magazine). In this issue, we’re
JAN-10(2)
December 21, 2015
No Comments
In this issue: Welcome to the home page of The CPI Antitrust Chronicle (formerly GCP Magazine). In this issue, we’re
Microsoft and the Court of First Instance: What Does it All Mean?
December 21, 2015
No Comments
This article is part of a Chronicle. See more from this Chronicle Renata Hesse, Oct 03, 2007 As someone who
Strong Spine, Weak Underbelly: The CFI Microsoft Decision
December 21, 2015
No Comments
This article is part of a Chronicle. See more from this Chronicle Harry First, Sep 28, 2007 INTRODUCTION The CFI’s
JAN-10(1)-Twelve of the Best from 2009
December 21, 2015
No Comments
In this issue: Welcome to the home page of The CPI Antitrust Chronicle (formerly GCP Magazine). We introduce our new
Oct-07(1)
December 21, 2015
No Comments
In this issue: More on Microsoft Harry First, Sep 28, 2007 Strong Spine, Weak Underbelly: The CFI Microsoft Decision The
Antitrust and Intellectual Property: Recent Developments in the Pharmaceuticals Sector
December 21, 2015
No Comments
William Michael, Aidan Synnott, Sep 24, 2009 During his campaign for the Presidency, then-Senator Barack Obama promised that he would
